Enveric Biosciences Inc (ENVB) Stock Analysis

Enveric Biosciences Inc (ENVB) is a publicly traded company in the HEALTHCARE sector. It trades at $2.22, carries a market capitalization of $8.47M. This page summarizes the public market data, fundamentals, and frequently asked questions for ENVB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Enveric Biosciences Inc currently has a Bullish sentiment score of 0.18.

About Enveric Biosciences Inc

Enveric Biosciences Inc. is a pioneering pharmaceutical company based in Florida, dedicated to developing cannabinoid-based therapeutics that significantly improve treatment outcomes for cancer patients. By leveraging its deep expertise in cannabinoid research, Enveric is focused on creating innovative drug candidates that target unmet medical needs and enhance the quality of life for individuals battling cancer. With a strong emphasis on clinical development, the company is strategically pos...

GNG Research Analysis

GNG Research scores Enveric Biosciences Inc (ENVB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ENVB.

Frequently Asked Questions

Does ENVB pay dividends?

Enveric Biosciences Inc (ENVB) does not currently pay a regular dividend.

What is ENVB's market cap?

Enveric Biosciences Inc (ENVB) has a market capitalization of $8.47M with a current stock price of $2.22.